The bought deal provided Invictus with the capital it needed to fully fund its investments and represented a significant development for the company.
An Execution Story
Since then, Invictus has continued to execute and advance its story and today, the company announced another milestone. Last month, Invictus’ ACMPR licensed production facility, AB Labs completed its first harvest. The company said that the second harvest occurred this week and expects to have monthly harvests going forward.
In April, Invictus completed its investment in AB Labs, which owns a 16,000 square-foot facility in Hamilton, Ontario that is licensed to cultivate cannabis. AB Labs is a fully operational licensed producer with distribution through Canopy Growth’s Tweed Main Street online store.
Over the next year, AB Labs will be able to significantly increase production capacity through AB Ventures, which completed the acquisition of 100 acres in Ontario. This land will be used to cultivate cannabis once the company is fully licensed under the ACMPR.
AB Ventures was formed to develop a second licensed expansion facility through its common ownership with AB Labs. AB Ventures is planning its Phase 1 expansion which initially includes the development of two 21,000 square foot, multiple room production facilities. The company engaged a development advisor to provide guidance at the pre-consultation stage for its site plan approval.
Invictus MD has committed to invest $5.5 million to fund the costs of licensing approval and construction of the initial production facilities (totaling 42,000 square foot). The company plans to complete the additional production facilities by 2019.
A Company to Watch
If Invictus can execute on its planned initiatives, the company will be positioned to become a leading licensed medical cannabis producer in Canada. Assuming that AB Ventures obtains a license to produce a scale at the proposed facility, there will additional production capacity to meet the demand for medical and recreational marijuana. If more production capacity is needed, the company can further expand on its 100-acre property.
Invictus MD Executive Chairman Dan Kriznic will assume responsibilities as Chairman and CEO of Invictus MD and Trevor Dixon will assume responsibilities as President and CEO of Acreage Pharms to facilitate the further expansion of that production site while achieving increased operational efficiencies.
Although Invictus has continued to execute, the shares have moved lower with the Canadian cannabis industry over the last quarter. Shares of Invictus are down 40% during this time and we view the valuation as attractive at these levels. We plan to keep an eye on the shares after yesterday’s move higher and will monitor how the company continues to execute.
Important Investor Disclosures
Paid affiliate.This report was authored by and is property of Technical420. All information and data relied upon in drafting this report is publicly available. The author believes and considers its sources to be reliable, but does not guarantee the accuracy or completeness of any information contained in this report. Any and all information, data, analyses and opinions are provided for informational purposes only and is not intended, in any manner, as investment advice. Any projections or other information generated by Technical420 regarding the likelihood of various investment outcomes are hypothetical in nature, do not reflect actual investment results, and are not guarantees of future results. None of the material contained in this report is intended as a solution or offer to sell or purchase a specific stock or any other investment. This report is not directed to, or intended for distribution or use by, any person or entity that is a citizen, resident or located in any municipality, state, country or other jurisdiction where the distribution, publication, availability, or use of this report is contrary to any governing law or regulation. The securities discussed in this report may not be eligible for purchase and/or sale in certain jurisdictions or by particular individuals. It is important that you check any and all governing laws and/or regulations that may be applicable in your jurisdiction. Investing in securities of issuers organized outside of the United States, including ADRs, entail certain risks. The securities of non-United States issuers may not be registered with, nor be subject to the reporting requirements of the United States Securities and Exchange Commission. Please contact a Financial Advisor for professional advice regarding any and all securities investments. This report is intended for informational purposes only
Source: Technical 420